March 2007
Quest Diagnostics (Lyndhurst, NJ) is still busy snapping up specialized IVD companies. This time the focus is at the point-of-care (POC). Quest has purchased HemoCue (Angelholm, Sweden), which specializes in POC testing, from the private equity firm EQT II B.V. in a cash transaction valued at approximately $420 million. With annualized revenues of approximately $90 million, HemoCue is the leading international provider in POC testing for hemoglobin, with a growing share in glucose and microalbumin testing. Washington G-2 Reports estimates that POC testing represents a worldwide market of approximately $5.5 billion and is growing at approximately 10% per year.
Subscribers: click here for the full story
Non-Subscribers: click here to subscribe
|
|
|
 Archives
|
|
March 2007 - Table of Contents
